Time to first decision without review:
Acceptance to publication:
Aims and scope
BMJ Innovations is a peer reviewed online journal focused on novel technologies, emerging digital health and pioneering medical devices. The journal champions high-quality original research, systemic and narrative reviews as well as early-stage innovation reports that are designed to accelerate transferable lessons from new health solutions. Along with a rich mix of news, discussion and debate BMJ Innovations aims to ensure innovators, clinicians, leaders and policy makers stay informed on are empowered to adopt the latest innovations that will make the biggest impact on health. The journal focuses on three broad areas of innovation:
- Digital health
- Medical devices
- Novel technologies
Plan S compliance
BMJ Innovations is owned by BMJ
Subscription; with hybrid open access option
Web of Science Core Collection: Emerging Sources Citation Index, Scopus, Embase (Excerpta Medica), Google Scholar Not currently indexed for MEDLINE. BMJ Innovations will deposit NIH funded manuscripts to PubMed Central as part of the NIH Public Access Policy.
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author
Acceptance rate: 34%
Speed Time to first decision without review (median): 24 days Time to first decision with review (median): 91 days Time from acceptance to publication (median): 19 days
Impact Citescore: 1.8 Citescore rank: 355/826 SciMago Journal Rank (SJR): 0.327
Reach 2022 total content views: 89,243 2022 total Altmetric mentions: 696
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics
For all contact information please refer to the contact us page.
Please refer to the Instructions for authors
Rights and Permissions
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues about the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. BMJ is a sponsor of its activities.